Cargando…
Expression of parvin-β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract
BACKGROUND: Parvin-β (ParvB), a potential tumour suppressor gene, is a focal adhesion protein. We evaluated the role of ParvB in the upper urinary tract urothelial cell carcinoma (UUT-UC). METHODS: ParvB mRNA and proteins levels in UUT-UC tissue were investigated by quantitative real-time polymerase...
Autores principales: | Wu, C-F, Ng, K-F, Chen, C-S, Chang, P-L, Chuang, C-K, Weng, W-H, Liao, S-K, Pang, S-T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966628/ https://www.ncbi.nlm.nih.gov/pubmed/20736946 http://dx.doi.org/10.1038/sj.bjc.6605835 |
Ejemplares similares
-
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
por: Dalpiaz, O, et al.
Publicado: (2014) -
Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract
por: Douglas, J, et al.
Publicado: (2014) -
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015) -
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013) -
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)